Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.41 |
| ▸ | TTPA | P49638 | 3/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9653516 | 0.85 | MEN1 (0.49) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL9313634 | 0.85 | MEN1 (0.50) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL9314064 | 0.84 | ALOX5 (0.44) | MEN1KMT2ATTPAALOX5 | |
| SCHEMBL9314035 | 0.81 | TTPA (0.47) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL9314074 | 0.79 | MEN1 (0.46) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL9313511 | 0.79 | MEN1 (0.49) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL10724913 | 0.75 | MEN1 (0.62) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL10724905 | 0.75 | MEN1 (0.62) | MEN1KMT2APDE4APDE3APTPN1 | |
| SCHEMBL9312762 | 0.75 | ALOX5 (0.46) | MEN1KMT2ATTPAALOX5 | |
| SCHEMBL9258885 | 0.74 | MEN1 (0.50) | MEN1KMT2APDE4APDE3APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5315017-A | Peroxidation and eicosanoid biosynthesis inhibition | ADIR ET COMPAGNIE (FR) | 1994-05-24 | — | — | US | disclosed |